Development of an isotoxic decision support system integrating genetic markers of toxicity for the implantation of a rectum spacer

Published on Jun 28, 2018in Acta Oncologica3.701
· DOI :10.1080/0284186X.2018.1484156
Yvonka van Wijk4
Estimated H-index: 4
(Maastricht University Medical Centre),
Ben G. L. Vanneste14
Estimated H-index: 14
(UM: Maastricht University)
+ 6 AuthorsPhilippe Lambin113
Estimated H-index: 113
(Maastricht University Medical Centre)
Sources
Abstract
AbstractIntroduction: Previous studies revealed that dose escalated radiotherapy for prostate cancer patients leads to higher tumor control probabilities (TCP) but also to higher rectal toxicities. An isotoxic model was developed to maximize the given dose while controlling the toxicity level. This was applied to analyze the effect of an implantable rectum spacer (IRS) and extended with a genetic test of normal tissue radio-sensitivity. A virtual IRS (V-IRS) was tested using this method. We hypothesized that the patients with increased risk of toxicity would benefit more from an IRS.Material and methods: Sixteen localized prostate cancer patients implanted with an IRS were included in the study. Treatment planning was performed on computed tomography (CT) images before and after the placement of the IRS and with a V-IRS. The normal tissue complication probability (NTCP) was calculated using a QUANTEC reviewed model for Grade > =2 late rectal bleeding and the number of fractions of the plans were adjusted ...
📖 Papers frequently viewed together
10 Citations
19 Citations
5 Citations
References33
Newest
#1Ben G. L. VannesteH-Index: 14
#2Y. van Wijk (UM: Maastricht University)H-Index: 2
Last. Aswin L. Hoffmann (UM: Maastricht University)H-Index: 17
view all 8 authors...
PURPOSE: To assess the effect of a shrinking rectal balloon implant (RBI) on the anorectal dose and complication risk during the course of moderately hypofractionated prostate radiotherapy. METHODS: In 15 patients with localized prostate cancer, an RBI was implanted. A weekly kilovolt cone-beam computed tomography (CBCT) scan was acquired to measure the dynamics of RBI volume and prostate-rectum separation. The absolute anorectal volume encompassed by the 2 Gy equieffective 75 Gy isodose (V75Gy)...
9 CitationsSource
#1Ben G. L. VannesteH-Index: 14
#2Kees van de Beek (UM: Maastricht University)H-Index: 5
Last. Philippe LambinH-Index: 113
view all 4 authors...
INTRODUCTION: A rectum balloon implant (RBI) is a new device to spare rectal structures during prostate cancer radiotherapy. The theoretical advantages of a RBI are to reduce the high radiation dose to the anterior rectum wall, the possibility of a post-implant correction, and their predetermined shape with consequent predictable position. OBJECTIVE: To describe, step-by-step, our mini-invasive technique for hands-free transperineal implantation of a RBI before start of radiotherapy treatment. M...
8 CitationsSource
#1Yvonka van WijkH-Index: 4
#2Ben G. L. Vanneste (UM: Maastricht University)H-Index: 14
Last. Philippe Lambin (UM: Maastricht University)H-Index: 113
view all 8 authors...
Abstract Introduction Previous studies have shown that the implantable rectum spacer (IRS) is not beneficial for all patients. A virtual IRS (V-IRS) was constructed to help identify the patients for whom it is cost-effective to implant an IRS, and its viability as a tool to tailor the decision of an IRS implantation to be beneficial for the specified patient was assessed. Please watch animation: ( https://www.youtube.com/watch?v=tDlagSXMKqw ) Materials and methods The V-IRS was tested on 16 pati...
10 CitationsSource
#1Philippe Lambin (Maastricht University Medical Centre)H-Index: 113
#2Jaap D. Zindler (Maastricht University Medical Centre)H-Index: 17
Last. Sean Walsh (Maastricht University Medical Centre)H-Index: 11
view all 39 authors...
Abstract A paradigm shift from current population based medicine to personalized and participative medicine is underway. This transition is being supported by the development of clinical decision support systems based on prediction models of treatment outcome. In radiation oncology, these models ‘learn’ using advanced and innovative information technologies (ideally in a distributed fashion — please watch the animation: http://youtu.be/ZDJFOxpwqEA ) from all available/appropriate medical data (c...
67 CitationsSource
#1Mathilda L. Bongers (VU: VU University Amsterdam)H-Index: 6
#2Dirk De RuysscherH-Index: 83
Last. Veerle M.H. Coupé (VU: VU University Amsterdam)H-Index: 29
view all 7 authors...
__Introduction:__ Optimizing radiotherapy with or without chemotherapy through advanced imaging and accelerated radiation schemes shows promising results in locally advanced non–small-cell lung cancer (NSCLC). This study compared the cost-effectiveness of positron emission tomography-computed tomography based isotoxic accelerated sequential chemo-radiation (SRT2) and concurrent chemo-radiation with daily low-dose cisplatin (CRT2) with standard sequential (SRT1) and concurrent chemo-radiation (CR...
1 CitationsSource
#1Ben G. L. Vanneste (UM: Maastricht University)H-Index: 14
#2Aswin L. Hoffmann (UM: Maastricht University)H-Index: 17
Last. Philippe Lambin (UM: Maastricht University)H-Index: 113
view all 6 authors...
Abstract Background and purpose Previous studies confirmed that implantable rectum spacers (IRS) decreased acute gastro-intestinal (GI) toxicity in a significant percentage of prostate cancer patients undergoing intensity modulated radiation therapy (IMRT). We developed decision rules based on clinical risk factors (CRFs) to select those patients who are expected to benefit most from IRS implantation. Materials and methods For 26 patients dose distributions with (IMRT+IRS) and without (IMRT−IRS)...
19 CitationsSource
#1Sarah L. Kerns (URMC: University of Rochester Medical Center)H-Index: 27
#2Leila Dorling (University of Cambridge)H-Index: 13
Last. Catharine M L WestH-Index: 77
view all 28 authors...
Nearly 50% of cancer patients undergo radiotherapy. Late radiotherapy toxicity affects quality-of-life in long-term cancer survivors and risk of side-effects in a minority limits doses prescribed to the majority of patients. Development of a test predicting risk of toxicity could benefit many cancer patients. We aimed to meta-analyze individual level data from four genome-wide association studies from prostate cancer radiotherapy cohorts including 1564 men to identify genetic markers of toxicity...
47 CitationsSource
#1Jaap D. Zindler (UM: Maastricht University)H-Index: 17
#2Charles R. Thomas (OHSU: Oregon Health & Science University)H-Index: 65
Last. Philippe Lambin (UM: Maastricht University)H-Index: 113
view all 6 authors...
To obtain a favorable tradeoff between treatment benefits and morbidity (“therapeutic ratio”), radiotherapy (RT) dose is prescribed according to the tumor volume, with the goal of controlling the disease while respecting normal tissue tolerance levels. We propose a new paradigm for tumor dose prescription in stereotactic ablative radiotherapy (SABR) based on organat-risk (OAR) tolerance levels called isotoxic dose prescription (IDP), which is derived from experiences and limitations of conventio...
18 CitationsSource
#1Indrin J. Chetty (HFHS: Henry Ford Health System)H-Index: 34
#2Mary K. Martel (University of Texas MD Anderson Cancer Center)H-Index: 44
Last. John Wong (Johns Hopkins University)H-Index: 78
view all 20 authors...
Radiation therapy is an effective, personalized cancer treatment that has benefited from technological advances associated with the growing ability to identify and target tumors with accuracy and precision. Given that these advances have played a central role in the success of radiation therapy as a major component of comprehensive cancer care, the American Society for Radiation Oncology (ASTRO), the American Association of Physicists in Medicine (AAPM), and the National Cancer Institute (NCI) s...
34 CitationsSource
#1Anusha Kalbasi (UPenn: University of Pennsylvania)H-Index: 16
#2Jiaqi Li (UPenn: University of Pennsylvania)H-Index: 8
Last. Justin E. Bekelman (UPenn: University of Pennsylvania)H-Index: 11
view all 9 authors...
Importance In 5 published randomized clinical trials, dose-escalated external-beam radiation therapy (EBRT) for prostate cancer resulted in improved biochemical and local control. However, scarce evidence addresses whether dose escalation improves overall survival. Objective To examine the association between dose-escalated EBRT and overall survival among men with nonmetastatic prostate cancer. Design, Setting, and Participants We conducted a retrospective, nonrandomized comparative effectivenes...
90 CitationsSource
Cited By5
Newest
#1Yvonka van Wijk (UM: Maastricht University)H-Index: 1
#2Bram Ramaekers (Maastricht University Medical Centre)H-Index: 17
Last. Philippe Lambin (UM: Maastricht University)H-Index: 113
view all 10 authors...
The aim of this study is to build a decision support system (DSS) to select radical prostatectomy (RP) or external beam radiotherapy (EBRT) for low- to intermediate-risk prostate cancer patients. We used an individual state-transition model based on predictive models for estimating tumor control and toxicity probabilities. We performed analyses on a synthetically generated dataset of 1000 patients with realistic clinical parameters, externally validated by comparison to randomized clinical trial...
Source
#1Nicola Rares Franco (Ghent University Hospital)H-Index: 1
#1Nicola Rares Franco (Ghent University Hospital)
Last. Tiziana RancatiH-Index: 27
view all 43 authors...
AIM To identify the effect of single nucleotide polymorphism (SNP) interactions on the risk of toxicity following radiotherapy (RT) for prostate cancer (PCa) and propose a new method for polygenic risk score incorporating SNP-SNP interactions (PRSi). MATERIALS AND METHODS Analysis included the REQUITE PCa cohort that received external beam RT and was followed for 2 years. Late toxicity endpoints were: rectal bleeding, urinary frequency, haematuria, nocturia, decreased urinary stream. Among 43 li...
Source
#1Scott Jones (QUT: Queensland University of Technology)H-Index: 1
#2Catriona Hargrave (QUT: Queensland University of Technology)H-Index: 5
Last. Kerrie Mengersen (QUT: Queensland University of Technology)H-Index: 72
view all 5 authors...
Purpose: Limiting the dose to the rectum can be one of the most challenging aspects of creating a dosimetric external beam radiation therapy (EBRT) plan for prostate cancer treatment. Rectal sparing devices such as hydrogel spacers offer the prospect of increased space between the prostate and rectum, causing reduced rectal dose and potentially reduced injury. This study sought to help identify patients at higher risk of developing rectal injury based on estimated rectal dosimetry compliance pri...
2 CitationsSource
#1Eva Onjukka (Karolinska University Hospital)H-Index: 4
#2Claudio FiorinoH-Index: 54
Last. Tiziana RancatiH-Index: 27
view all 11 authors...
AbstractPurpose: The aim of this work was to determine how the spatial pattern of dose in the ano-rectal wall is related to late gastro-intestinal toxicity for prostate cancer patients treated with...
8 CitationsSource
#1Y. van Wijk (UM: Maastricht University)H-Index: 2
#1Y. Van Wijk (UM: Maastricht University)H-Index: 2
Last. Ben G. L. Vanneste (UM: Maastricht University)H-Index: 14
view all 7 authors...
Background. A multifactorial decision support system (mDSS) is a tool designed to improve the clinical decision-making process, while using clinical inputs for an individual patient to generate case-specific advice. The study provides an overview of the literature to analyze current available mDSS focused on prostate cancer (PCa), in order to better understand the availability of decision support tools as well as where the current literature is lacking. Methods. We performed a MEDLINE literature...
5 CitationsSource
#1Michael Trager (Thomas Jefferson University Hospital)H-Index: 1
#2Benjamin A. Greenberger (Thomas Jefferson University Hospital)H-Index: 6
Last. Robert B. Den (Thomas Jefferson University Hospital)H-Index: 42
view all 5 authors...
High-dose-rate (HDR) brachytherapy is an attractive option for patients receiving definitive radiation therapy for prostate cancer with decreased overall dose to the pelvis. However, ulcerative colitis increases rectal toxicity risk and may be a contraindication. A synthetic hydrogel, SpaceOAR (Augmentix Inc., Waltham, MA, USA), can facilitate the use of HDR brachytherapy for patients where rectal toxicity is a limiting factor. SpaceOAR gel (13.19 cc) was utilized in a monotherapy HDR prostate t...
2 CitationsSource